课题基金 / 基金详情

SEX DIFFERENCES IN PHARMACOKINETICS OF LOPINAVIR/RITONAVIR AMONG HIV-1 INFECT

SEX DIFFERENCES IN PHARMACOKINETICS OF LOPINAVIR/RITONAVIR AMONG HIV-1 INFECT
HIV-1 感染者中洛匹那韦/利托那韦药代动力学的性别差异
批准号:
7717997
负责人:
Judith S. Currier
金额:
$1.23万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2008-11-30

项目摘要

项目成果

Judith S. Currier的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 具体目标 比较目前接受相似剂量洛匹那韦/利托那韦(LPV/RTV)的HIV-1感染男性和女性的药物动力学参数(PK)、洛比那韦(LPV)的浓度-时间曲线下面积(AUC)。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. SPECIFIC AIMS To compare the pharmacokinetic (PK) parameter, area under the concentration-time curve (AUC) of Lopinavir (LPV) between HIV-1-infected men and women currently receiving similar doses of Lopinavir/ritonavir (LPV/RTV).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
CoVPN 3008 A Phase 3, Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
UCLA-CDU CFAR